Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Relationship between adherence to a plant-based diet delivered via an mHealth app through primary care on inflammation: analyses in adults at high cardiovascular risk from the CHEAP trial

FY 2023-24

Summary
The global rise in noncommunicable diseases, notably ischemic heart disease, is a major threat in Canada to healthcare systems and economies. Clinical guidelines recommend diet and lifestyle to address these threats, there is limited time for physicians and coverage for dietitians, impeding nutrition counseling. Technology-based interventions can engage physicians and patients, saving time and costs. The Portfolio Diet, a plant-based diet of cholesterol-lowering foods, which has demonstrated clinically meaningful reductions in LDL-C and cardiovascular risk factors, is uniquely positioned to test this innovative approach. My research objective is to assess the clinical impact of our Portfolio Diet Program (PortfolioDiet.app plus 16-session online behaviour change curriculum and provision of key foods), as a transformative digitally based translation of the Canadian Cardiovascular Society clinical practice guidelines for dyslipidemia in primary care. I will conduct a pragmatic, open-label, randomized trial, recruiting physicians through primary care practice-based research networks to randomize 1100 secondary [70%] and high-risk primary [30%] prevention participants on background statin therapy to either the Portfolio Diet Program as add-on therapy to standard of care or standard of care alone. Participants will be assessed at baseline and 1y. The primary outcome is the proportion achieving a ?8% reduction in LDL-C or non-HDL-C at 1y and changes in inflammatory markers as part of secondary outcomes. The demonstration that the Portfolio Diet Program can reduce cardiovascular risk, while improving patient-provider relationships and healthcare costs, will have major influence on implementing clinical practice guidelines in primary care with a ready-to-use clinical tool.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506195
Name
Silva Constança
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Relationship between adherence to a plant-based diet delivered via an mHealth app through primary care on inflammation: analyses in adults at high cardiovascular risk from the CHEAP trial
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular Risk Factors; Cholesterol-Lowering Foods; Coronary Heart Disease; Dietary Guidelines; Dyslipidemia; Healthcare App; Nutrition; Plant-Based Diet; Portfolio Diet; Primary Care
Abstract
The global rise in noncommunicable diseases, notably ischemic heart disease, is a major threat in Canada to healthcare systems and economies. Clinical guidelines recommend diet and lifestyle to address these threats, there is limited time for physicians and coverage for dietitians, impeding nutrition counseling. Technology-based interventions can engage physicians and patients, saving time and costs. The Portfolio Diet, a plant-based diet of cholesterol-lowering foods, which has demonstrated clinically meaningful reductions in LDL-C and cardiovascular risk factors, is uniquely positioned to test this innovative approach. My research objective is to assess the clinical impact of our Portfolio Diet Program (PortfolioDiet.app plus 16-session online behaviour change curriculum and provision of key foods), as a transformative digitally based translation of the Canadian Cardiovascular Society clinical practice guidelines for dyslipidemia in primary care. I will conduct a pragmatic, open-label, randomized trial, recruiting physicians through primary care practice-based research networks to randomize 1100 secondary [70%] and high-risk primary [30%] prevention participants on background statin therapy to either the Portfolio Diet Program as add-on therapy to standard of care or standard of care alone. Participants will be assessed at baseline and 1y. The primary outcome is the proportion achieving a ?8% reduction in LDL-C or non-HDL-C at 1y and changes in inflammatory markers as part of secondary outcomes. The demonstration that the Portfolio Diet Program can reduce cardiovascular risk, while improving patient-provider relationships and healthcare costs, will have major influence on implementing clinical practice guidelines in primary care with a ready-to-use clinical tool.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Silva, Constança
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~